SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending after reporting stronger-than-expected earnings and robust guidance, driven by significant U.S. commercial and government demand for its AI platform. This has ignited community debate, with bulls celebrating an "iconic performance" and expecting further upside, while skeptics question the company's high valuation despite the impressive growth.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending due to the recent xAI and SpaceX merger, with community discussion highlighting SMCI's integral role in building xAI's "Colossus" supercomputer and fueling expectations of significant future revenue ahead of its anticipated earnings report, despite ongoing debates about margin pressures and a potential short squeeze.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood ($HOOD) is trending due to a steep stock decline, heavily influenced by recent cryptocurrency market weakness, particularly Bitcoin's fall, and concerns over declining crypto trading volumes and prediction market activity. The community is sharply divided, with some seeing the drop as a "capitulation" and a strong buying opportunity supported by institutional buys and oversold technicals, while others are bearish, attributing the weakness to its crypto correlation and broader market uncertainty ahead of its upcoming earnings.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is buzzing after reports surfaced about its plans for a potential IPO of its T-Head AI chip unit and China's approval for major tech firms, including Alibaba, to prepare orders for Nvidia H200 AI chips, igniting community optimism for its aggressive AI and cloud expansion and a potential re-rating.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending intensely ahead of its expected earnings report, with community sentiment sharply divided between those who view the fintech giant as a deeply undervalued cash-generating machine poised for a turnaround, and others convinced it's a stagnant company facing relentless competition and further declines. Investors are eagerly awaiting clarity on management's strategy to combat perceived market share loss and capitalize on new growth initiatives amidst a prevailing bearish narrative despite low valuation metrics.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to fervent community speculation around a "monumental" acquisition by CEO Ryan Cohen, with targets like Best Buy widely discussed, reigniting intense "meme stock" enthusiasm and expectations of a significant short squeeze.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as its Waymo autonomous driving unit recently secured a major funding round, significantly boosting its valuation, which is fueling community anticipation for strong AI-driven earnings and a perceived leadership advantage over rivals in the AI race.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending ahead of its Q4 earnings report, with community sentiment sharply divided between those anticipating a strong rebound driven by user growth and new AR/AI initiatives, and others expressing deep skepticism over profitability and management given competitive and regulatory pressures.

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Atossa Therapeutics Inc

Atossa Therapeutics (ATOS) is heavily discussed following its approved 1-for-15 reverse stock split, effective February 2, 2026, which the community largely views as a detrimental move signaling future dilution and concerns over CEO Steven Quay's management.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva Pharmaceutical is generating significant buzz following its robust Q4 earnings, strong performance from its branded drug portfolio, and a key funding agreement with Royalty Pharma for its vitiligo treatment. Community discussion centers on the impressive momentum of the "Pivot to Growth" strategy and new drug developments, with many anticipating continued upside despite some calls for an overdue pullback after its recent extended rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Great Lakes Advisors LLC Decreases Stake in Pacira BioSciences, Inc. $PCRX

Great Lakes Advisors LLC lessened its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 51.3% in the third quarter, according to the company in its most recent filing with...

Gagnon Securities LLC Grows Stock Holdings in Pacira BioSciences, Inc. $PCRX

Gagnon Securities LLC boosted its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 22.1% in the third quarter, according to the company in its most recent 13F filing with...

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Recommendation of "Hold" by Analysts

Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) have been given a consensus rating of "Hold" by the six analysts that are currently covering the company, MarketBeat reports. One...

Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why 

Pacira (PCRX) could produce exceptional returns because of its solid growth attributes.

Will Pacira (PCRX) Beat Estimates Again in Its Next Earnings Report?

Pacira (PCRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Pacira BioSciences (NASDAQ:PCRX) Hits New 52-Week Low - Time to Sell?

Pacira BioSciences (NASDAQ:PCRX) Reaches New 12-Month Low - Time to Sell...

Do Options Traders Know Something About Pacira BioSciences Stock We Don't?

Investors need to pay close attention to PCRX stock based on the movements in the options market lately.

Pacira BioSciences (NASDAQ:PCRX) Shares Down 6.9% - What's Next?

Pacira BioSciences (NASDAQ:PCRX) Stock Price Down 6.9% - Time to Sell...

PCRX, LG Chem Partner to Expand Exparel Reach Across the Asia-Pacific

Pacira BioSciences teams up with LG Chem to expand Exparel across Asia-Pacific, unlocking royalties and new revenue channels to support international growth.

PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates

Pacira BioSciences stock slides nearly 10% after preliminary Q4 revenues of $196.9 million miss estimates, despite Exparel sales topping forecasts.

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Pacira BioSciences Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $AMD earnings on Tuesday?

Current Price	$21.22
Prev Close	$20.54
Open	$20.53
Dividend Yield	0.00%
50-Day Moving Average	$23.69
Beta	0.38
Avg. Volume	1.07M
PE Ratio	47.57

52-Week High	$27.64
52-Week Low	$18.80
Market Capitalization	$883.66M
EPS (Annual)	-$2.15
Price to Book	1.25
Revenue Per Employee	$887,298.73
Enterprise Value/EBITDA	N/A

PCRX
Pacira BioSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PCRX News

PCRXPacira BioSciences Inc